GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Bundamedik Tbk (ISX:BMHS) » Definitions » PE Ratio (TTM)

PT Bundamedik Tbk (ISX:BMHS) PE Ratio (TTM) : 204.89 (As of Dec. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PT Bundamedik Tbk PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-13), PT Bundamedik Tbk's share price is Rp268.00. PT Bundamedik Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was Rp1.31. Therefore, PT Bundamedik Tbk's PE Ratio (TTM) for today is 204.89.

Good Sign:

PT Bundamedik Tbk stock PE Ratio (=207.95) is close to 1-year low of 198.44


The historical rank and industry rank for PT Bundamedik Tbk's PE Ratio (TTM) or its related term are showing as below:

ISX:BMHS' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 27.85   Med: 53.04   Max: 487.8
Current: 214.35


During the past 6 years, the highest PE Ratio (TTM) of PT Bundamedik Tbk was 487.80. The lowest was 27.85. And the median was 53.04.


ISX:BMHS's PE Ratio (TTM) is ranked worse than
96.17% of 392 companies
in the Healthcare Providers & Services industry
Industry Median: 22.775 vs ISX:BMHS: 214.35

PT Bundamedik Tbk's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was Rp0.10. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was Rp1.31.

As of today (2024-12-13), PT Bundamedik Tbk's share price is Rp268.00. PT Bundamedik Tbk's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was Rp1.26. Therefore, PT Bundamedik Tbk's PE Ratio without NRI for today is 212.53.

During the past 6 years, PT Bundamedik Tbk's highest PE Ratio without NRI was 641.71. The lowest was 27.69. And the median was 52.48.

PT Bundamedik Tbk's EPS without NRI for the three months ended in Sep. 2024 was Rp0.18. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was Rp1.26.

During the past 12 months, PT Bundamedik Tbk's average EPS without NRI Growth Rate was -27.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -59.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.60% per year.

During the past 6 years, PT Bundamedik Tbk's highest 3-Year average EPS without NRI Growth Rate was 268.80% per year. The lowest was -59.00% per year. And the median was 61.60% per year.

PT Bundamedik Tbk's EPS (Basic) for the three months ended in Sep. 2024 was Rp0.10. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was Rp1.60.


PT Bundamedik Tbk PE Ratio (TTM) Historical Data

The historical data trend for PT Bundamedik Tbk's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Bundamedik Tbk PE Ratio (TTM) Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio (TTM)
Get a 7-Day Free Trial N/A N/A 18.86 42.47 362.22

PT Bundamedik Tbk Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 244.20 362.22 468.83 209.78 218.65

Competitive Comparison of PT Bundamedik Tbk's PE Ratio (TTM)

For the Medical Care Facilities subindustry, PT Bundamedik Tbk's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Bundamedik Tbk's PE Ratio (TTM) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where PT Bundamedik Tbk's PE Ratio (TTM) falls into.



PT Bundamedik Tbk PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

PT Bundamedik Tbk's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=268.00/1.308
=204.89

PT Bundamedik Tbk's Share Price of today is Rp268.00.
PT Bundamedik Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp1.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


PT Bundamedik Tbk  (ISX:BMHS) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


PT Bundamedik Tbk PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of PT Bundamedik Tbk's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Bundamedik Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.

PT Bundamedik Tbk Headlines

No Headlines